Wednesday, November 25, 2009, 11:06am EST - Canadian Markets close in 4 hours and 54 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

SuperGen Inc. (SUPG)

 At 10:51 EST: 2.7501 USD  Down 0.0099 (0.36%)  
MORE ON SUPG
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
SuperGen, Inc. (NGM:SUPG) Delayed quote dataEdit
Last Trade: 2.7501 USD
Trade Time: 10:51AM EST
Change: Down 0.0099 (0.36%)
Prev Close: 2.76
Open: 2.74
Bid: 2.75 x 1500
Ask: 2.76 x 7600
1y Target Est: 10.00
Day's Range: 2.72 - 2.78
52wk Range: 1.54 - 3.30
Volume: 44,388
Avg Vol (3m): 239,711
Market Cap: 165.39M
P/E (ttm): 98.22
EPS (ttm): 0.028
Div & Yield: N/A (N/A%)
SuperGen Inc. (SUPG)
1d  5d  3m  6m  1y  2y  5y  max 
 Add SUPG to Portfolio   Download Data

HEADLINES
• Biotech Stocks for a Possible Year-End Rally
at Seeking Alpha (Wed, Nov 18)
• SUPERGEN INC Financials
EDGAR Online Financials (Fri, Nov 13)
• SuperGen to Present at Lazard Healthcare Conference on November 18, 2009
Business Wire (Wed, Nov 11)
• SUPERGEN INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Nov 9)
• SuperGen Presentations at AACR-NCI-EORTC
Business Wire (Mon, Nov 9)
• SuperGen to Present at Merriman Curhan Ford Investor Summit on November 10, 2009
Business Wire (Wed, Nov 4)
• 5-Star Stocks on the Upswing
at Motley Fool (Mon, Nov 2)
• SUPERGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities,
EDGAR Online (Wed, Oct 28)
• SuperGen-Glaxo Deal Couldn't Have Come at a Better Time
at Seeking Alpha (Tue, Oct 27)
• SuperGen, Inc.Q3 2009 Earnings Call Transcript
at Seeking Alpha (Mon, Oct 26)
• SuperGen Earnings Call scheduled for 4:30 pm ET today
CCBN (Mon, Oct 26)
• SuperGen Reports 2009 Third Quarter Financial Results
Business Wire (Mon, Oct 26)
More Headlines for SUPG...
ANALYST
EPS Est (next year) (Dec-07) : 0.19
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 2.8
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
SuperGen, Inc., a pharmaceutical company, engages in the discovery, acquisition, development, and commercialization of therapies to treat patients with cancer.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices